PH-0047 CTV and OAR robustness of clinical neuro IMPT: dosimetric impact of the DUPROTON robustness protocol
| Autor: | Rojo Santiago, J., Habraken, S.J., Lathouwers, D., Méndez Romero, A., Perkó, Z., Hoogeman, M.S. |
|---|---|
| Zdroj: | In Radiotherapy and Oncology August 2021 161 Supplement 1:S22-S24 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect